Dr. Wamser + Batra India Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
- Paid Up Capital ₹ 1.80 M
- Company Age 17 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 31.99%
- Profit Growth 301.30%
- Ebitda 378.75%
- Net Worth 40.43%
- Total Assets 12.59%
About Dr. Wamser + Batra India
Dr. Wamser + Batra India Private Limited (DWBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 January 2008 and has a history of 17 years. Its registered office is in New Delhi, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 1.80 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Pandey, Karsten Echle, and Karl Freedman serve as directors at the Company.
Company Details
-
Location
New Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U70200DL2008PTC173278
-
Company No.
173278
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2008
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dr. Wamser + Batra India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karsten Echle
|
Director | 26-Sep-2018 | Current |
Karl Freedman
|
Director | 01-Apr-2022 | Current |
Rajesh Pandey
|
Director | 26-Sep-2018 | Current |
Financial Performance of Dr. Wamser + Batra India.
Dr. Wamser + Batra India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.99% increase. The company also saw a substantial improvement in profitability, with a 301.3% increase in profit. The company's net worth Soared by an impressive increase of 40.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Wamser + Batra India?
In 2023, Dr. Wamser + Batra India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wb Trade And Services Private LimitedRajesh Pandey, Karsten Echle and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Wamser + Batra India?
Unlock and access historical data on people associated with Dr. Wamser + Batra India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Wamser + Batra India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Wamser + Batra India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
